A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT06254950 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06254950
- Sponsor
- Takeda
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-29
- Primary completion
- 2026-07-14
- Enrollment
- 213
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.